Gilead Science was supposed to be coming back as a company on the heels of its first major acquisition in years. Unfortunately, the post-earnings reaction has not been any help on that front.
Esperion Therapeutics released its first-quarter financial results and a business update before the markets opened on Wednesday.
Gilead Sciences released disappointing first-quarter financial results late Tuesday and shares tumbled early Wednesday.
In some parts of the country, infestations of dangerous mosquitoes, ticks and fleas will make the outdoor activity risky, according to the CDC.
Karyopharm Therapeutics saw its shares make a handy gain on Tuesday after the firm announced positive top-line results from the Phase 2b STORM study evaluating selinexor.
Regeneron Pharmaceuticals and Sanofi are committing to lowering the price of the anti-cholesterol drug Praluent.
Gilead Sciences is set to report its most recent quarterly results after the markets close on Tuesday, the first since an announced collaboration with Sangamo Therapeutics.
AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch tender auction.
Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.
Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.
Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These are the two biggest companies in the pharma industry and they can set the…
Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public offering valued up to almost $104 million.
SteadyMed saw its shares skyrocket early on Monday after the company announced that it would be acquired by United Therapeutic.
Johnson & Johnson just delivered yet another dividend hike. The company previously had committed to increasing its dividends over and over.
Alexion Pharmaceuticals released better-than-expected first-quarter financial results before the markets opened on Thursday.
